TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Kashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Patiala’s cardio metabolic physician at Chicago's Premier Diabetes conference

Dr Sanjay Singla presented his revolutionary research on ‘Understanding Early Disease Trajectories and Their Relationship to Microvascular Complications’
Dr Sanjay Singla's recognition at Chicago's premier diabetes platform marks a milestone for Indian medical excellence on the global stage.

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Cardio metabolic physician from Patiala Dr Sanjay Singla represented India at the American Diabetes Association's 85th Scientific Sessions in Chicago — the world's largest diabetes conference with over 11,000 global attendees.

Advertisement

Dr Singla presented his revolutionary research on ‘Understanding Early Disease Trajectories and Their Relationship to Microvascular Complications’. His AI-powered study can predict diabetes complications up to 2 years before clinical diagnosis, offering hope for millions of patients worldwide. The research addresses a critical challenge: identifying which patients will develop severe complications like diabetic retinopathy, nephropathy, and neuropathy — and when.

Advertisement

Global Recognition

Being selected to present at the ADA Scientific Sessions, places Dr Singla among the world's elite diabetes researchers. He was one from only 3 such researchers selected from India.

Real-World Impact

Advertisement

Dr Singla's work transforms diabetes care from reactive to predictive, enabling doctors to intervene before complications develop. This is particularly significant as microvascular complications affect 37.5% of diabetes patients globally.

Advertisement
Tags :
#ADA2024#AIinHealthcare#DiabetesCare#DiabetesPrediction#DiabetesResearch#DiabeticComplications#DiabeticRetinopathy#EarlyDiagnosis#IndianDoctor#MicrovascularComplications
Show comments
Advertisement